Providing progressive cancer treatment and compassionate care.

Cancer News – 2018

  • May Is National Skin Cancer Detection and Prevention Month

    Sun Valley, ID —OMNI Health  (OMNI) announces the launch of skin cancer programs for national skin cancer detection and prevention month. As the month of May brings skin cancer into focus, it’s time to increase public understanding of the disease, including its prevalence, approaches to screening and prevention, treatment options, and resources that offer updated … Continue reading "May Is National Skin Cancer Detection and Prevention Month" […]

  • PARP – Checkpoint Inhibitor Combo Promising in Ovarian Cancer

    CancerConnect News: The combination of a PARP inhibitor and a checkpoint inhibitor appears promising as treatment for patients with ovarian cancer, according to results of a clinical study reported at the 2018 Society for Gynecologic Oncology Annual Meeting on Women’s Cancer in New Orleans, Louisiana.  Preliminary results from the study suggest that the combination could provide meaningful … Continue reading "PARP – Checkpoint Inhibitor Combo Promising in Ovarian Cancer" […]

  • What is a Venous Access Device and What Types are Used for Cancer Patients?

    A venous access device (VAD) is a surgically implanted device that provides long-term access to a major vein. A VAD can be useful for patients undergoing systemic treatment with precision cancer medicines or chemotherapy because it allows for a single access that can be used repeatedly to draw blood and deliver medications thus avoiding frequent … Continue reading "What is a Venous Access Device and What Types are Used for Cancer Patients?" […]

  • Smoking and Cancer: Understand the Risk and What You Can Do to Control It

    CancerConnect News: Smoking tobacco cigarettes is responsible for drastically increasing the risk of the developing lung cancer— the number-one cause of cancer-related deaths in the U.S—as well as several other types of cancer (not to mention additional diseases).[1] Tobacco use, primarily from cigarettes, is considered the single most preventable cause of death in this country. … Continue reading "Smoking and Cancer: Understand the Risk and What You Can Do to Control It" […]

  • FDA Approves Tafinlar® + Mekinist® for Adjuvant Treatment of BRAF V600-mutant Stage III Melanoma

    CancerConnect News: The US Food and Drug Administration (FDA) has approved Tafinlar® (dabrafenib) in combination with Mekinist® (trametinib) for the adjuvant treatment of patients with stage III melanoma with BRAF V600E or V600K mutations, as detected by an FDA-approved test.1 About Melanoma  Stage III melanoma includes cancers of any thickness that have spread to the … Continue reading "FDA Approves Tafinlar® + Mekinist® for Adjuvant Treatment of BRAF V600-mutant Stage III Melanoma" […]

  • U.S. FDA Grants Fast Track Designation to GemRIS™ in Muscle Invasive Bladder Cancer

    CancerConnect News: The United States Food and Drug Administration (FDA) has granted Fast Track designation for GemRIS™ (TAR-200) for the treatment of patients with organ-confined or locally-advanced Muscle Invasive Bladder Cancer who are unfit for curative intent therapy. About Muscle Invasive Bladder Cancer Bladder cancer is the fifth most common neoplasm in industrialized countries, affecting … Continue reading "U.S. FDA Grants Fast Track Designation to GemRIS™ in Muscle Invasive Bladder Cancer" […]

  • Lutathera Pepetide Receptor Radionuclide Therapy for NETs

    CancerConnect News: Lutathera (lutetium Lu 177 dotatate) was recently approved for the treatment of neuroendocrine tumors (NETs) that typically occur in the pancreas and gastrointestinal tract. This is the first time a radioactive drug, or radiopharmaceutical, has been approved for the treatment of NETs. PRRT and NET NET is an abbreviation for Neuro-Endocrine Tumor. These … Continue reading "Lutathera Pepetide Receptor Radionuclide Therapy for NETs" […]

  • Immediate vs Delayed Androgen Deprivation Therapy in Prostate Cancer

    CancerConnect News: There is an ongoing discussion about the optimal timing of using androgen deprivation therapy (ADT) in men with prostate cancer who have relapsed based on a rising prostate-specific antigen (PSA) and in men with early stage prostate cancer who are unable to receive more aggressive treatment. Some experts believe that ADT should be … Continue reading "Immediate vs Delayed Androgen Deprivation Therapy in Prostate Cancer" […]

  • Many Early Onset Colon Cancers are Caused by Genetic Mutations Passed Through Families

    CancerConnect News: One in every six colorectal cancer patients (16 percent) diagnosed under age 50 has at least one inherited genetic mutation that increases his or her cancer risk and many of these mutations could go undetected with the current screening approach, according to initial data from a statewide colorectal cancer screening study conducted at … Continue reading "Many Early Onset Colon Cancers are Caused by Genetic Mutations Passed Through Families" […]

  • Alcensa Provides Longer Symptom Improvement than Xalkori in ALK-positive Lung Cancer

    CancerConnect News: Alecensa (alectinib) provides longer symptom improvement than Xalkori (crizotinib) in ALK-positive non-small-cell lung cancer (NSCLC), according to results presented at the European Lung Cancer Congress in in Geneva, Switzerland.1 About ALK + NSCLC Lung cancer is the leading cause of cancer death in the U.S. and around the world, highlighting the importance of … Continue reading "Alcensa Provides Longer Symptom Improvement than Xalkori in ALK-positive Lung Cancer" […]